ERBB2 and neoplasm: Some prognostic tumor biomarkers in GC such as human epidermal growth factor receptor 2 (HER2), vascular endothelial growth factor (VEGF), epidermal growth factor receptor (EGFR), have been associated with disease characteristics and can therefore be used to inform patient management.